ECSS
NBP

Eurizon Capital SGR SpA’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Eurizon Capital SGR SpA’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Hold
1
– – ﹤0.01% 1236
2026
Q1 		$2 Hold
1
– – ﹤0.01% 1192
2025
Q4 		$4 Buy
+1
New +$4 ﹤0.01% 1088

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIHC Capital Management Central $104M AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Eurizon Capital SGR SpA's NBP Position: Q2 2026 in Review

Eurizon Capital SGR SpA held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q2 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #1236.

Eurizon Capital SGR SpA first reported a position in NBP in Q4 2025 and has held it in 3 quarters since. The position peaked at $4 in Q4 2025. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Eurizon Capital SGR SpA held 1 share of NovaBridge Biosciences American Depositary Shares worth $2 as of Q2 2026.
  • Eurizon Capital SGR SpA left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q2 2026.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #1236 holding.
  • Eurizon Capital SGR SpA first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2025 and has held it in 3 quarters since.
  • Eurizon Capital SGR SpA's NovaBridge Biosciences American Depositary Shares position peaked at $4 in Q4 2025.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.